Related references
Note: Only part of the references are listed.Protein phosphatase 2A regulatory subunits and cancer
Pieter J. A. Eichhorn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells
Sara E. Bass et al.
CLINICAL CANCER RESEARCH (2009)
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
Danilo Perrotti et al.
CANCER AND METASTASIS REVIEWS (2008)
A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins
Hugh K. Arnold et al.
CANCER AND METASTASIS REVIEWS (2008)
Structural mechanism of demethylation and inactivation of protein phosphatase 2A
Yongna Xing et al.
CELL (2008)
Heme oxygenase-1 and carbon monoxide in vascular pathobiology
Jozef Dulak et al.
CIRCULATION (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Dithiolethiones for cancer chemoprevention: where do we stand?
Yuesheng Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
The PP2A inhibitor SET regulates natural killer cell IFN-γ production
Rossana Trotta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation
Wen-Jie Cai et al.
CARDIOVASCULAR RESEARCH (2007)
Selection of protein phosphatase 2A regulatory Subunits is mediated by the C terminus of the catalytic subunit
Sari Longin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine mono phosphate-activated protein kinase-p70 ribosomal s6 kinase-1 pathway
Eun Ju Bae et al.
HEPATOLOGY (2007)
The tumor suppressor PP2A Aβ regulates the RaIA GTPase
Anna A. Sablina et al.
CELL (2007)
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid
J. S. Isenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative
Ling Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
R. L. Dillon et al.
ONCOGENE (2007)
Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity
Geraldine Rocher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The α4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A
Todd D. Prickett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism
Daniela Sarnataro et al.
MOLECULAR PHARMACOLOGY (2006)
Integrin-linked kinase activity is associated with interleukin-1a-induced progressive behavior of pancreatic cancer and poor patient survival
H. Sawai et al.
ONCOGENE (2006)
Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction
Annette Schmidt et al.
MICROVASCULAR RESEARCH (2006)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway
Jerome Busserolles et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
mTOR•RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes
RC Hresko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nrf2 as a novel molecular target for chemoprevention
JS Lee et al.
CANCER LETTERS (2005)
Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol
D Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein phosphatase 2A negatively Akt (protein kinase B) activity in 3T3-L1 adipocytes
S Ugi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
Y Matsuoka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway - Identification of novel gene clusters for cell survival
MK Kwak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of integrin-linked kinase (ILK) in cancer progression
S Persad et al.
CANCER AND METASTASIS REVIEWS (2003)
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
J Liang et al.
NATURE MEDICINE (2002)
A novel cAMP-stimulated pathway in protein phosphatase 2A activation
MS Feschenko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Protein phosphatase 2A forms a molecular complex with Shc and regulates shc tyrosine phosphorylation and downstream mitogenic signaling
S Ugi et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes
S Resjo et al.
CELLULAR SIGNALLING (2002)
Fibronectin, integrins, and growth control
EHJ Danen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones
MK Kwak et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
V Janssens et al.
BIOCHEMICAL JOURNAL (2001)
Modulation of Akt kinase activity by binding to Hsp90
S Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)